Takeshi Ebihara
Overview
Explore the profile of Takeshi Ebihara including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
36
Citations
181
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ito H, Ebihara T, Matsumoto H, Oda J
Sci Rep
. 2025 Jan;
15(1):2470.
PMID: 39833390
Circulating growth differentiation factor 15 (GDF-15) increases in response to inflammation and tissue damage. Its association with functional prognosis in cerebral infarction and subarachnoid hemorrhage is established; however, its role...
2.
Nishida T, Tachino J, Yokono Y, Ebihara T, Matsumoto H, Ogura H, et al.
QJM
. 2024 Dec;
PMID: 39663186
No abstract available.
3.
Priest D, Ebihara T, Tulyeu J, Sondergaard J, Sakakibara S, Sugihara F, et al.
Nat Commun
. 2024 Aug;
15(1):6811.
PMID: 39122676
Resting memory B cells can be divided into classical or atypical groups, but the heterogenous marker expression on activated memory B cells makes similar classification difficult. Here, by longitudinal analysis...
4.
Okita T, Kita S, Fukuda S, Kondo Y, Sakaue T, Iioka M, et al.
Biochem Biophys Res Commun
. 2024 Jul;
732:150403.
PMID: 39047402
Aim And Objective: Our recent report showed that soluble T-cadherin promotes pancreatic beta-cell proliferation. However, how and where the secretion of soluble T-cadherin is regulated remain unclear. Methods And Results:...
5.
Kumazaki S, Hikita H, Tahata Y, Sung J, Fukumoto K, Myojin Y, et al.
Aliment Pharmacol Ther
. 2024 Jun;
60(3):327-339.
PMID: 38828944
Background And Aims: Although metabolic dysfunction-associated steatotic liver disease (MASLD) patients with a Fib-4 index >1.3 are recommended for fibrosis evaluation via elastography or biopsy, a more convenient method identifying...
6.
Yoshimura J, Togami Y, Ebihara T, Matsumoto H, Mitsuyama Y, Sugihara F, et al.
Microbiol Spectr
. 2023 Nov;
11(6):e0264523.
PMID: 37966347
In this study, whole-blood RNAs (prolactin and toll-like receptor 3) involved in the prognosis of patients with COVID-19 were identified. The RNA endotypes classified by these important RNAs highlight the...
7.
Kawakami E, Saiki N, Yoneyama Y, Moriya C, Maezawa M, Kawamura S, et al.
Cell Stem Cell
. 2023 Oct;
30(10):1315-1330.e10.
PMID: 37802037
COVID-19 is linked to endotheliopathy and coagulopathy, which can result in multi-organ failure. The mechanisms causing endothelial damage due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) remain elusive. Here,...
8.
Onishi S, Matsumoto H, Sugihara F, Ebihara T, Matsuura H, Osuka A, et al.
iScience
. 2023 Jul;
26(8):107271.
PMID: 37502255
Recent advancements in proteomics allow for the concurrent identification and quantification of multiple proteins. This study aimed to identify proteins associated with severe burn pathology and establish a clinically useful...
9.
Ebihara T, Shimizu K, Mitsuyama Y, Ogura H, Oda J
J Physiol Anthropol
. 2023 May;
42(1):7.
PMID: 37208712
No abstract available.
10.
Ebihara T, Shimizu K, Mitsuyama Y, Ogura H, Oda J
J Physiol Anthropol
. 2023 Apr;
42(1):6.
PMID: 37055843
Background: Acute mountain sickness (AMS) affects around 30% of people climbing Mt. Fuji, but its pathogenesis is incompletely understood. The influence of a rapid ascent to high altitude by climbing...